Madi Sun

Guangzhou, 510006, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Corrigendum to 'One-pot synthesis of chlorhexidine-templated biodegradable mesoporous organosilica nanoantiseptics' [Colloid. Surf. B: Biointerfaces 187(2019)110653].

Corrigendum to 'One-pot synthesis of chlorhexidine-templated biodegradable mesoporous organosilica nanoantiseptics' [Colloid. Surf. B: Biointerfaces 187(2019)110653].

Journal: Colloids and surfaces. B, Biointerfaces
Published: December 20, 2024

An Engineered Nanoplatform with Tropism Toward Irradiated Glioblastoma Augments Its Radioimmunotherapy Efficacy.

An Engineered Nanoplatform with Tropism Toward Irradiated Glioblastoma Augments Its Radioimmunotherapy Efficacy.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: December 26, 2023

Hepatic-Accumulated Obeticholic Acid and Atorvastatin Self-Assembled Nanocrystals Potentiate Ameliorative Effects in Treatment of Metabolic-Associated Fatty Liver Disease.

Hepatic-Accumulated Obeticholic Acid and Atorvastatin Self-Assembled Nanocrystals Potentiate Ameliorative Effects in Treatment of Metabolic-Associated Fatty Liver Disease.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 18, 2023

Engineering a biomimetic system for hepatocyte-specific RNAi treatment of non-alcoholic fatty liver disease.

Engineering a biomimetic system for hepatocyte-specific RNAi treatment of non-alcoholic fatty liver disease.

Journal: Acta biomaterialia
Published: July 20, 2023

Circulating Cell-Free DNAs as a Biomarker and Therapeutic Target for Acetaminophen-Induced Liver Injury.

Circulating Cell-Free DNAs as a Biomarker and Therapeutic Target for Acetaminophen-Induced Liver Injury.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 19, 2022

A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease.

A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease.

Journal: Science advances
Published: January 28, 2022

Biomimetic co-assembled nanodrug of doxorubicin and berberine suppresses chemotherapy-exacerbated breast cancer metastasis.

Biomimetic co-assembled nanodrug of doxorubicin and berberine suppresses chemotherapy-exacerbated breast cancer metastasis.

Journal: Biomaterials
Published: September 28, 2020

Berberine Inhibits the Apoptosis-Induced Metastasis by Suppressing the iPLA2/LOX-5/LTB4 Pathway in Hepatocellular Carcinoma.

Berberine Inhibits the Apoptosis-Induced Metastasis by Suppressing the iPLA2/LOX-5/LTB4 Pathway in Hepatocellular Carcinoma.

Journal: OncoTargets and therapy
Published: December 22, 2019

One-pot synthesis of chlorhexidine-templated biodegradable mesoporous organosilica nanoantiseptics.

One-pot synthesis of chlorhexidine-templated biodegradable mesoporous organosilica nanoantiseptics.

Journal: Colloids and surfaces. B, Biointerfaces
Published: July 28, 2019

Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers.

Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers.

Journal: Science advances
Published: July 11, 2019

Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.

Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.

Journal: Acta biomaterialia
Published: July 02, 2019

5-FU preferably induces apoptosis in BRAF V600E colorectal cancer cells via downregulation of Bcl-xL.

5-FU preferably induces apoptosis in BRAF V600E colorectal cancer cells via downregulation of Bcl-xL.

Journal: Molecular and cellular biochemistry
Published: May 10, 2019
Showing 1-12 of 16

Last Updated: 09/26/2026